METOPIMAZINE ARROW 7.5 mg sugar-free, orodispersible tablet sweetened with aspartame 16 tablets
Active ingredients: Metopimazine
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METOPIMAZINE ARROW 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartam
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 16 comprimé(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62073158CIP73027409CIP133400930274095Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTOPIMAZINEcomprimé | 7,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.